Biotech company Cargo Therapeutics is laying off 90% of its workforce after plans to suspend its drug development, according to a corporate filing. The San Carlos-based company expects $24 million to ...
Sutro Biopharma, a Bay Area oncology biotech company, is laying off around half its staff, switching up its leadership team ...
Atomwise, a San Francisco AI drug discovery startup, raises $44M+ in Series C funding and appoints Steve Worland as CEO to ...
The approach isn't new. App developers sometimes seek financial support from avid users and medical research institutions ...
A Bay Area biotech company is laying off half of its staff amid what it is calling a “strategic portfolio review.” Sutro ...
Eater SF on MSN12h
Why a 30-Year-Old Winery Is Betting Big on an Eccentric MakeoverOne big name in Napa Valley wine is trying its hand at modernizing, and they’re leaning into one of its winemaker’s artsy, ...
News Medical on MSN15d
FairJourney Biologics Acquires Charles River Laboratories South San Francisco FacilityFairJourney Biologics S.A., leaders in the discovery and optimization of antibodies, today announced that it had completed the acquisition of the South San Francisco site from Charles River ...
AWS and Cisco partner PTP acquires two MSPs in Stratogent and Protocol Networks to boost cloud services and AI for life ...
Officers, beneficial owners, and other insiders have shelled out more than $10 million on each of these four biotech stocks ...
SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — FibroGen Inc. (FGEN) on Monday reported net income of $18 million in its fourth quarter. The San Francisco-based company said it had profit of 18 cents per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback